Consequently, although preliminary, our data suggests that CPX 5, endowed with a considerably improved water solubility and a significant scaffold-assisted anti-cancer activity, can become a promising formulation for the protracted release of ETO in order to sensitize NB cells. The gene discussed is RUNX1T1; the disease is cancer.